BUZZ-Aeterna Zentaris Inc: Licenses drug to China-based company
** Canadian company's U.S.-listed shares up 13.5 pct at 60 cents in early trading
** Toronto-listed shares up 9.8 pct at 67 Canadian cents
** Company licenses lead anti-cancer compound zoptarelin doxorubicin to China-based Sinopharm A-Think Pharmaceuticals Co Ltd for $1 mln
** Aeterna Zentaris licenses rights to develop the drug in China, Hong Kong and Macao
** Up to Friday's close, Aeterna's U.S. shares had slumped about 62 pct this year
© Thomson Reuters 2017 All rights reserved.